Quantcast

Posts Tagged: Gene Quinn


The Zup™ is perhaps the most cool and innovative wake board you have ever seen. There are a number of other patent applications pending, trademark applications pending and ongoing research and development for future products. The Zup™ is special …

Continue Reading

Rachael Lamkin is a patent litigator who recently became Associate General Counsel at Blue Ocean Enterprises, Inc. I have known Rachael virtually for several years, communicating with her both via e-mail and via …

Continue Reading

You can expect a near complete cessation in many areas of personalized medicine. If creating something in a lab, such as a composite cDNA, does not make the underlying claims patent eligible because what results is indistinguishable from what …

Continue Reading

There is no doubt that the Obama position will be loved by Google and other Silicon Valley technology giants that despise the patent system. Given the revolving door between the Obama Administration and Google, the long-term close relationship between …

Continue Reading

When writing a claim it is important to describe how the various components are structured and how the various components interact and connect. First, include a claim that defines your invention in broad terms, leaving out any and all …

Continue Reading

On May 9, 2013, IPWatchdog’s very own Gene Quinn will be attending and presenting at the Business Development Institute’s Social Media Marketing Summit for Law Firms in NY. The summit was put together as a result of increased awareness …

Continue Reading

Let's face it, squeezing more energy from the suns rays is not an easy challenge otherwise we would have done it already. Capturing power from the winds isn't the silver bullet solution and many more advances need to take …

Continue Reading

Collecting the information necessary to prepare a patent application covering a computer related invention can be quite challenging. Typically, most computer related inventions today relate at least in some way to software, which is at the core of the …

Continue Reading

Two common criticisms of software patents, as compared to patents in the pharmaceutical and biotech sectors, are (a) the relatively low cost of invention; and (b) the relative ease of implementation. Are these the right factors for us to …

Continue Reading

There are some exceptions whereby a person who files second can still prevail, but those exceptions are infinitesimally insignificant, and the law surrounding the parameters of the exceptions is non-existent and unfortunately rather ill defined by the USPTO at …

Continue Reading

Those that do the complaining erroneously state that they speak on behalf of the entire industry. But I know they don't speak for IBM, or Qualcomm or Tessera or the many other innovative companies that exist in the high-tech …

Continue Reading

A patent is a proprietary right granted by the United States federal government to an inventor who files a patent application with the United States Patent Office. Therefore, unlike copyright and trademark protection, patent protection will only exist upon …

Continue Reading